Publications

1. Limburg PJ, Mandrekar SJ, Aubry MC, Ziegler KL, Zhang J, Yi JE, Henry M, Tazelaar HD, Lam S, McWilliams A, Midthun DE, Edell ES, Rickman OB, Mazzone P, Tockman M, Beamis JF, Lamb C, Simoff M, Loprinzi C, Szabo E, Jett J, Cancer Prevention Network. Randomized phase II trial of sulindac for lung cancer chemoprevention. Lung Cancer. 2013 Mar; 79(3):254-61. Epub 2012 Dec 20. 2302535
   View PubMed
2. Jett JR, Schild SE, Kesler KA, Kalemkerian GP. Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl):e400S-19S. 2326363
   
3. Pecot CV, Li M, Zhang XJ, Rajanbabu R, Calitri C, Bungum A, Jett JR, Putnam JB, Callaway-Lane C, Deppen S, Grogan EL, Carbone DP, Worrell JA, Moons KG, Shyr Y, Massion PP. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev. 2012 May; 21(5):786-92. Epub 2012 Feb 28. 2236809
   View PubMed
4. Reungwetwattana T, Molina JR, Mandrekar SJ, Allen-Ziegler K, Rowland KM, Reuter NF, Luyun RF, Dy GK, Marks RS, Schild SE, Jett JR, Adjei AA. Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study. J Thorac Oncol. 2012 May; 7(5):919-22. 2246523
   View PubMed
5. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, Shepherd FA. Non-small-cell lung cancer. Lancet. 2011 Nov 12; 378(9804):1727-40. Epub 2011 May 10. 2208964
   View PubMed
6. Jett JR, Midthun DE. Screening for lung cancer: for patients at increased risk for lung cancer, it works. Ann Intern Med. 2011 Oct 18; 155(8):540-2. Epub 2011 Sep 05. 2187849
   View PubMed
7. Cuffe S, Moua T, Summerfield R, Roberts H, Jett J, Shepherd FA. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol. 2011 Apr; 6(4):818-22. 2166819
   View PubMed
8. Foster NR, Qi Y, Shi Q, Krook JE, Kugler JW, Jett JR, Molina JR, Schild SE, Adjei AA, Mandrekar SJ. Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials. Cancer. 2011 Mar 15; 117(6):1262-71. Epub 2010 Oct 19. 2121159
   View PubMed
9. Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, Jett JR. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest. 2010 Dec; 138(6):1295-302. Epub 2010 Mar 26. 1992790
   View PubMed
10. Khattar NH, Coe-Atkinson SP, Stromberg AJ, Jett JR, Hirschowitz EA. Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer. Cancer Biol Ther. 2010 Aug 1; 10(3):267-72. Epub 2010 Aug 18. 2112815
    View PubMed
11. Bryce AH, Mattar B, Hillman SL, Adjei AA, Kugler JW, Rowland K Jr, Wender DB, Soori G, Perez EA, Jett JR. Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: A North Central Cancer Treatment Group Study. Am J Clin Oncol. 2010 Aug; 33(4):353-7. 1974090
    View PubMed
12. Maldonado F, Jett JR. Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis. Curr Opin Pulm Med. 2010 Jul; 16(4):315-20. 1987765
    View PubMed
13. Chee CE, Jett JR, Bernath AM Jr, Foster NR, Nelson GD, Molina J, Nikcevich DA, Steen PD, Flynn PJ, Rowland KM Jr. Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive-stage small cell lung cancer, N0423. Cancer. 2010 May 15; 116(10):2382-9. 1990487
    View PubMed
14. Voss JS, Kipp BR, Halling KC, Henry MR, Jett JR, Clayton AC, Rickman OB. Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens. Am J Respir Crit Care Med. 2010 Mar 1; 181(5):478-85. Epub 2009 Dec 10. 1977218
    View PubMed
15. Jett JR. State of the journal: 2010. J Thorac Oncol. 2010 Mar; 5(3):289-90. 1988629
    View PubMed
16. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Mandrekar JN. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest. 2009 Dec; 136(6):1586-95. Epub 2009 Jul 06. 1952602
    View PubMed
17. Heffner JE, Holgate ST, Chung KF, Niederman MS, Daley CL, Jett JR, Stradling JR, Wells AU, Light RW, Tapson VF, Hansell DM, Provonost PJ, Lee YC. Road ahead to respiratory health: experts chart future research directions. Respirology. 2009 Jul; 14(5):625-36. Epub 2009 Mar 11. 1965721
    View PubMed
18. Wilcox BE, Subramaniam RM, Peller PJ, Aughenbaugh GL, Nichols Iii FC, Aubry MC, Jett JR. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clin Lung Cancer. 2009 Jul; 10(4):244-8. 1954817
    View PubMed
19. Foster NR, Mandrekar SJ, Schild SE, Nelson GD, Rowland KM, Deming RL, Kozelsky TF, Marks RS, Jett JR, Adjei AA. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer. 2009 Jun 15; 115(12):2721-31. 1939152
    View PubMed
20. Lara PN Jr, Natale R, Crowley J, Lenz HJ, Redman MW, Carleton JE, Jett J, Langer CJ, Kuebler JP, Dakhil SR, Chansky K, Gandara DR. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol. 2009 May 20; 27(15):2530-5. Epub 2009 Apr 06. 1935367
    View PubMed
21. Yang P, Mandrekar SJ, Hillman SH, Allen Ziegler KL, Sun Z, Wampfler JA, Cunningham JM, Sloan JA, Adjei AA, Perez E, Jett JR. Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study. J Thorac Oncol. 2009 Apr; 4(4):479-85. 2106806
    View PubMed
22. Subramaniam RM, Wilcox B, Aubry MC, Jett J, Peller PJ. 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma. J Med Imaging Radiat Oncol. 2009 Apr; 53(2):160-9; quiz 170. 1949870
    View PubMed
23. Jett JR, Socinski MA. Introduction. Proceedings of the American Thoracic Society. 2009; 6(2):151. 1978632
    View PubMed
24. Travis WD, Giroux DJ, Chansky K, Crowley J, Asamura H, Brambilla E, Jett J, Kennedy C, Rami-Porta R, Rusch VW, Goldstraw P, International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2008 Nov; 3(11):1213-23. 1990433
    View PubMed
25. Lim E, Goldstraw P, Nicholson AG, Travis WD, Jett JR, Ferolla P, Bomanji J, Rusch VW, Asamura H, Skogseid B, Baudin E, Caplin M, Kwekkeboom D, Brambilla E, Crowley J. Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007. J Thorac Oncol. 2008 Oct; 3(10):1194-201. 1955076
    View PubMed
26. Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc. 2008 Aug; 83(8):917-22. 1894782
    View PubMed
27. Mateen FJ, Jatoi A, Lineberry TW, Aranguren D, Creagan ET, Croghan GA, Jett JR, Marks RS, Molina JR, Richardson RL. Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology. 2008 Jul; 17(7):721-5. 1904645
    View PubMed
28. Midthun DE, Jett JR. Update on screening for lung cancer. Semin Respir Crit Care Med. 2008 Jun; 29(3):233-40. 1899074
    View PubMed
29. Kelly K, Chansky K, Gaspar LE, Albain KS, Jett J, Ung YC, Lau DH, Crowley JJ, Gandara DR. Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. J Clin Oncol. 2008 May 20; 26(15):2450-6. Epub 2008 Mar 31. 1906513
    View PubMed
30. Johnson EA, Marks RS, Mandrekar SJ, Hillman SL, Hauge MD, Bauman MD, Wos EJ, Moore DF, Kugler JW, Windschitl HE, Graham DL, Bernath AM Jr, Fitch TR, Soori GS, Jett JR, Adjei AA, Perez EA. Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer. 2008 May; 60(2):200-7. Epub 2007 Nov 28. 1899076
    View PubMed
31. Jett JR, Midthun DE. Commentary: CT screening for lung cancer--caveat emptor. Oncologist. 2008 Apr; 13(4):439-44. 1904647
    View PubMed
32. Brawner EJ, Nana-Sinkam SP, Jett JR. Lung cancer screening in 2008: A review and update. Respiratory Medicine CME. 2008; 1(1):2-9. 1978714
    View PubMed
33. Bach PB, Silvestri GA, Hanger M, Jett JR, American College of Chest Physicians. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):69S-77S. 1844628
    View PubMed
34. Jett JR, Schild SE, Keith RL, Kesler KA, American College of Chest Physicians. Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):266S-276S. 1844622
    View PubMed
35. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA, North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the Mayo The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer. 2007 Jul 15; 110(2):363-8. 2235261
    View PubMed
36. Rami-Porta R, Ball D, Crowley J, Giroux DJ, Jett J, Travis WD, Tsuboi M, Vallieres E, Goldstraw P, International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007 Jul; 2(7):593-602. 1834974
    View PubMed
37. Aubry MC, Thomas CF Jr, Jett JR, Swensen SJ, Myers JL. Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients. Chest. 2007 Jun; 131(6):1635-43. Epub 2007 Mar 30. 1828104
    View PubMed
38. Adjei AA, Molina JR, Mandrekar SJ, Marks R, Reid JR, Croghan G, Hanson LJ, Jett JR, Xia C, Lathia C, Simantov R. Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancer. Clin Cancer Res. 2007 May 1; 13(9):2684-91. 1818776
    View PubMed
39. Garces YI, Okuno SH, Schild SE, Mandrekar SJ, Bot BM, Martens JM, Wender DB, Soori GS, Moore DF Jr, Kozelsky TF, Jett JR. Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):995-1001. 1815246
    View PubMed
40. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007 Mar 7; 297(9):953-61. 1810402
    View PubMed
41. Jett JR. JTO: An Excellent First Year! J Thorac Oncol. 2007 Mar; 2(3):171-2. 1812299
    View PubMed
42. Huschka MM, Mandrekar SJ, Schaefer PL, Jett JR, Sloan JA. A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer. 2007 Feb 15; 109(4):787-95. 1807256
    View PubMed
43. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, Mandrekar JN. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007 Feb; 242(2):555-62. 1807101
    View PubMed
44. Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest. 2007 Jan; 131(1):255-60. 1802362
    View PubMed
45. Gandara DR, Aberle D, Lau D, Jett J, Akhurst T, Heelan R, Mulshine J, Berg C, Patz EF Jr. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. J Thorac Oncol. 2006 Nov; 1(9 Suppl):S20-6. 1856808
    View PubMed
46. Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer. Chest. 2006 Oct; 130(4):1211-9. 1789305
    View PubMed
47. Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest. 2006 Sep; 130(3):694-701. 1782567
    View PubMed
48. Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer. 2006 Aug 15; 107(4):781-92. 1779588
    View PubMed
49. Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1106-11. Epub 2006 May 26. 1770149
    View PubMed
50. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thor Oncol. 2006 Jul; 1(6):513-9. 1772879
    View PubMed
51. Mandrekar SJ, Northfelt DW, Schild SE, Foster NR, Bot B, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Adjei AA, Jett JR. Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials. J Thorac Oncol. 2006 Jul; 1(6):556-63. 1772880
    View PubMed
52. Molina JR, Jett JR, Foster N, Lair BS, Carroll TJ, Tazelaar HD, Hillman S, Mailliard JA, Bernath AM Jr, Nikcevich D. Phase II NCCTG trial of oral topotecan and paclitaxel with G-CSF (filgrastim) support in patients with previously untreated extensive-stage small cell lung cancer. Am J Clin Oncol. 2006 Jun; 29(3):246-51. 1765219
    View PubMed
53. Molina JR, Nikcevich D, Hillman S, Geyer S, Drevyanko T, Jett J, Verdirame J, Tazelaar H, Rowland K, Wos E, Kutteh L, Nair S, Fitch T, Flynn P, Stella P, Adjei AA. A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer. Cancer Invest. 2006 Jun-Jul; 24(4):382-9. 1770009
    View PubMed
54. Jett JR, Miller YE. Update in lung cancer 2005. Am J Respir Crit Care Med. 2006 Apr 1; 173(7):695-7. 1757138
    View PubMed
55. Dy GK, Jett JR, Geoffroy FJ, Krewer KD, Tazelaar H, Maurer M, Rowland K, Mailliard J, Krook J, Dakhil S, Kutteh L, Kugler J, Wender D. Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group. J Thorac Oncol. 2006 Mar; 1(3):211-7. 1772805
    View PubMed
56. Thomas CF Jr, Jett JR. Bronchial Carcinoid Tumors. UpToDate. 2006. 1872594
    
57. Jatoi A, Hillman S, Stella P, Green E, Adjei A, Nair S, Perez E, Amin B, Schild SE, Castillo R, Jett JR, North Central Cancer Treatment Group. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol. 2005 Dec 20; 23(36):9113-9. 2256051
    View PubMed
58. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med. 2005 Nov 15; 172(10):1308-14. 1733879
    View PubMed
59. Dy GK, Miller AA, Mandrekar SJ, Aubry MC, Langdon RM Jr, Morton RF, Schild SE, Jett JR, Adjei AA. A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study. Ann Oncol. 2005 Nov; 16(11):1811-6. Epub 2005 Aug 08. 1732265
    View PubMed
60. Ma CX, Nair S, Thomas S, Mandrekar SJ, Nikcevich DA, Rowland KM, Fitch TR, Windschitl HE, Hillman SL, Schild SE, Jett JR, Obasaju C, Adjei AA, North Central Cancer Treatment Group, Mayo Clinic, Eli Lilly & Company. Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer. J Clin Oncol. 2005 Sep 1; 23(25):5929-37. 2288919
    View PubMed
61. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med. 2005 Sep; 11(5):431-7. 1730042
    View PubMed
62. Giordano KF, Jatoi A, Adjei AA, Creagan ET, Croghan G, Frytak S, Jett JR, Marks R, Molina J, Okuno S, Richardson RL. Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution. Lung Cancer. 2005 Aug; 49(2):209-15. 1729980
    View PubMed
63. Jett JR. Limitations of screening for lung cancer with low-dose spiral computed tomography. Clin Cancer Res. 2005 Jul 1; 11(13 Pt 2):4988s-4992s. 1726769
    View PubMed
64. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Nathan MA, Lowe VJ. Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population. AJR Am J Roentgenol. 2005 Jul; 185(1):126-31. 1720604
    View PubMed
65. Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES, Thibodeau S, Adjei AA, Jett J, Deschamps C. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest. 2005 Jul; 128(1):452-62. 1721405
    View PubMed
66. Schild SE, Stella PJ, Brooks BJ, Mandrekar S, Bonner JA, McGinnis WL, Mailliard JA, Krook JE, Deming RL, Adjei AA, Jatoi A, Jett JR. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer. 2005 Jun 1; 103(11):2349-54. 1718765
    View PubMed
67. Ashton RW, Jett JR. Screening for non-small cell lung cancer. Semin Oncol. 2005 Jun; 32(3):253-8. 1718740
    View PubMed
68. Townsend CO, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, Swensen SJ, Hurt RD. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005 May 15; 103(10):2154-62. 1716419
    View PubMed
69. Strauss GM, Dominioni L, Jett JR, Freedman M, Grannis FW. Como international conference position statement - Lung cancer screening for early diagnosis 5 years after the 1998 Varese Conference. Chest. 2005 Apr; 127(4):1146-51. 1708093
    View PubMed
70. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, Sykes AM, Aughenbaugh GL, Bungum AO, Allen KL. CT screening for lung cancer: five-year prospective experience. Radiology. 2005 Apr; 235(1):259-65. Epub 2005 Feb 04. 1705035
    View PubMed
71. Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, Bennett WP, Jones RT, Borkowski A, Caporaso NA, Fleming M, Trastek V, Pairolero P, Tazelaar H, Midthun D, Jett JR, Liotta LA, Travis WD, Harris CC. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res. 2005 Jan 1; 11(1):232-41. 1677902
    View PubMed
72. Amin B, Hillman S, Nikcevich D, Dakhil S, Mailliard J, Fitch T, Bernath, Jr. A, Jett J, Perez E Randomized Phase II Study of Docetaxel and Gemcitabine for Stage IIIB/IV Non-Small Cell Lung Cancer: An NCCTG study Lung Cancer. 2005. 2010472
    View PubMed
73. Jatoi A, Jett JR, Sloan J, Novotny P, Ford J, Prabhakar U, Loprinzi CL. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer. 2004 Dec; 12(12):859-63. Epub 2004 Sep 15. 1677755
    View PubMed
74. David O, Jett J, LeBeau H, Dy G, Hughes J, Friedman M, Brody AR. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. Clin Cancer Res. 2004 Oct 15; 10(20):6865-71. 1669268
    View PubMed
75. Svobodnik A, Yang P, Novotny PJ, Bass E, Garces YI, Jett JR, Bonner JA, Sloan JA. Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. Mayo Clin Proc. 2004 Aug; 79(8):1024-30. 1657414
    View PubMed
76. Crestanello JA, Allen MS, Jett JR, Cassivi SD, Nichols FC, Swensen SJ, Deschamps C, Pairolero PC. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg. 2004 Aug; 128(2):254-9. 1660714
    View PubMed
77. Schild SE, Bonner JA, Shanahan TG, Brooks BJ, Marks RS, Geyer SM, Hillman SL, Farr GH Jr, Tazelaar HD, Krook JE, Geoffroy FJ, Salim M, Arusell RM, Mailliard JA, Schaefer PL, Jett JR. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):943-51. 1653805
    View PubMed
78. Visbal AL, Williams BA, Nichols FC III, Marks RS, Jett JR, Aubry MC, Edell ES, Wampfler JA, Molina JR, Yang P. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg. 2004 Jul; 78(1):209-15. 1653021
    View PubMed
79. Kraemer PS, Sanchez CA, Goodman GE, Jett J, Rabinovitch PS, Reid BJ. Flow cytometric enrichment for respiratory epithelial cells in sputum. Cytometry Part A. 2004 Jul; 60A(1):1-7. 1653751
    View PubMed
80. Jett JR, Midthun DE. Screening for lung cancer: Current status and future directions - Thomas A. Neff lecture. Chest. 2004 May; 125(5 Suppl S):158S-162S. 1647124
    View PubMed
81. Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, Nirelli LM, Vickers K, Hurt RD, Swensen SJ. Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer. 2004 Apr; 44(1):13-21. 1641274
    View PubMed
82. Nadrous HF, Allen NS, Bartholmai BJ, Aughenbaugh GL, Lewis JT, Jett JR. Glomus tumor of the trachea: Value of multidetector computed tomographic virtual bronchoscopy. Mayo Clin Proc. 2004 Feb; 79(2):237-40. 1519926
    View PubMed
83. Ramalingam S, Belani CP, Day R, Zamboni BA, Jacobs SA, Jett JR. Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer. Ann Oncol. 2004 Feb; 15(2):247-51. 1520585
    View PubMed
84. Cox LS, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, Swensen SJ, Hurt RD. Change in smoking status after spiral chest computed tomography scan screening. Cancer. 2003 Dec 1; 98(11):2495-501. 1425166
    View PubMed
85. Jett JR. Superior sulcus tumors and Pancoast's syndrome. Lung Cancer. 2003 Dec; 42(Suppl 2):S17-S21. 1431603
    View PubMed
86. Ma CX, Hobday TJ, Jett JR. Imatinib mesylate-induced interstitial pneumonitis. Mayo Clin Proc. 2003 Dec; 78(12):1578-9. 1429081
    View PubMed
87. Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study. Am J Clin Oncol. 2003 Oct; 26(5):441-7. 1417067
    View PubMed
88. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR, North Central Cancer Treatment Group. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol. 2003 Sep 1; 21(17):3201-6. Epub 2003 Jul 21. 2118454
    View PubMed
89. Jatoi A, Hillman S, Stella PJ, Mailliard JA, Sloan J, Vanone S, Cannon MW, Kutteh L, Kanard A, Jett JR. Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer. 2003 Jul; 11(7):460-4. 1407434
    View PubMed
90. Jett JR, Hatfield AK, Hillman S, Bauman MD, Mailliard JA, Kugler JW, Morton RF, Marks RS, Levitt R. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma - A Phase II trial of the North Central Cancer Treatment Group. Cancer. 2003 May 15; 97(10):2498-503. 1346770
    View PubMed
91. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Sykes AM, Aughenbaugh GL, Clemens MA. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003 Mar; 226(3):756-61. 1318947
    View PubMed
92. Jett JR, Scott WJ, Rivera MP, Sause WT. Guidelines on treatment of stage IIIB non-small cell lung cancer. Chest. 2003 Jan; 123(1 Suppl S):221S-225S. 1318233
    View PubMed
93. Jatoi A, Hillman S, Stella P, Mailliard J, Sloan J, Vanone S, Cannon M, Kutteh L, Kanard A, Jett J Activities of Daily Living: Exploring their Spectrum and Prognostic Impact in Older, Chemotherapy-Treated Lung Cancer Patients Supportive Care in Cancer. 2003; 7:460-464. 2003497
    View PubMed
94. Jett J, Hatfield A, Hillman S, Bauman M, Mailliard J, Kugler J, Morton R, Marks R, Levitt R Alternating Chemotherapy with Etoposide/Cisplatin and Topotecan/Paclitaxel in Patients with Untreated Extensive Stage Small Cell Lung Cancer: A Phase II Trial of the North Central Cancer Treatment Group Cancer. 2003:2498-2503. 2003371
    View PubMed
95. Colby TV, Tazelaar HD, Travis WD, Bergstralh EJ, Jett JR. Pathologic review of the Mayo Lung Project - Is there a case for misdiagnosis or overdiagnosis of lung carcinoma in the screened group? Cancer. 2002 Dec 1; 95(11):2361-5. 1317103
    View PubMed
96. Schild SE, Stella PJ, Geyer SM, Bonner JA, Marks RS, McGinnis WL, Goetz SP, Kuross SA, Mailliard JA, Kugler JW, Schaefer PL, Jett JR. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54(2):370-8. 1316237
    View PubMed
97. Jett JR. How to optimize staging in early non-small cell lung cancer. Lung Cancer. 2002 Oct; 38(1):S13-6. 1316967
    View PubMed
98. Kishi K, Gurney JW, Schroeder DR, Scanlon PD, Swensen SJ, Jett JR. The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study. Eur Respir J. 2002 Jun; 19(6):1093-8. 1315288
    View PubMed
99. Taniguchi K, Yang P, Jett J, Bass E, Meyer R, Wang Y, Deschamps C, Liu W. Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. Clin Cancer Res. 2002 Apr; 8(4):1115-20. 1315505
    View PubMed
100. Yang P, Yokomizo A, Tazelaar HD, Marks RS, Lesnick TG, Miller DL, Sloan JA, Edell ES, Meyer RL, Jett J, Liu W. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung Cancer. 2002 Mar; 35(3):221-9. 1008341
     View PubMed
101. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC, Pairolero PC. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002 Feb 15; 165(4):508-13. 1008280
     View PubMed
102. Sloan JA, Bonner JA, Hillman SL, Allmer C, Shanahan TG, Brooks BJ, Marks RS, Vargas-Chanes D, Jett JR. A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1). Int J Radiat Oncol Biol Phys. 2002 Feb 1; 52(2):371-81. 1007991
     View PubMed
103. Sloan JA, Bonner JA, Hillmann SL, Allmer C, Shanahan TG, Brooks BJ, Marks S, Vargas D, Jett JR. A quality-adjusted re-analysis of a phase III trial comparing once-daily thoracic radiation versus twice-daily thoracic radiation in patients with limited stage small cell lung cancer. Journal of Clinical Oncology. 2002; 52:371-81. 1122663
     
104. Okuno SH, Jett JR. Small cell lung cancer: current therapy and promising new regimens. Oncologist. 2002; 7(3):234-8. 1315878
     View PubMed
105. Colon-Otero G, Niedringhaus RD, Hillman SH, Geyer S, Sloan J, Krook JE, Windschitl HE, Marks RS, Wiesenfeld M, Tschetter LK, Jett JJ, North Central Cancer Treatment Group. A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial. Am J Clin Oncol. 2001 Dec; 24(6):551-5. 1979800
     View PubMed
106. Nicholson SA, Okby NT, Khan MA, Welsh JA, McMenamin MG, Travis WD, Jett JR, Tazelaar HD, Trastek V, Pairolero PC, Corn PG, Herman JG, Liotta LA, Caporaso NE, Harris CC. Alterations of p14(ARF), p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. Cancer Res. 2001 Jul 15; 61(14):5636-43. 1005713
     View PubMed
107. Thomas CF Jr, Tazelaar HD, Jett JR. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement. Chest. 2001 Apr; 119(4):1143-50. 1004792
     View PubMed
108. Allen MS, Jett JR, Kozelsky TF. Stage II (T3) lung cancer. Chest Surg Clin N Am. 2001 Feb; 11(1):61-7. 1004487
     View PubMed
109. Schiller JH, Adak S, Feins RH, Keller SM, Fry WA, Livingston RB, Hammond ME, Wolf B, Sabatini L, Jett J, Kohman L, Johnson DH. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy. J Clin Oncol. 2001 Jan 15; 19(2):448-57. 1003480
     View PubMed
110. Sloan J, Bonner J, Hillman S, Allmer C, Shanahan T, Brooks B, Marks R, Vargas-Chanes D, Jett J A quality-adjusted re-analysis of a phase III trial comparing once-daily thoracic radiation in patients with limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys. 2001. 2003339
     View PubMed
111. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA, Harris CC. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res. 2000 Dec; 6(12):4739-44. 1013715
     View PubMed
112. Weitz JJ, Marschke RF Jr, Sloan JA, Grill JP, Jett JR, Knost JA, Hatfield AK, Zenk DW, Bate WW, Schaefer PL. A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer. Lung Cancer. 2000 May; 28(2):157-62. 132669
     View PubMed
113. Adjei AA, Erlichman C, Sloan JA, Reid JM, Pitot HC, Goldberg RM, Peethambaram P, Atherton P, Hanson LJ, Alberts SR, Jett J. Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors. J Clin Oncol. 2000 Apr; 18(8):1748-57. 131975
     View PubMed
114. Midthun DE, Swensen SJ, Jett JR. Solitary pulmonary nodule: new face on an old problem. J Respir Dis. 2000; 21(4):270-276. 134168
     
115. Jett JR. Screening for lung cancer in high-risk groups: current status of low-dose spiral CT scanning and sputum markers. Seminars in Respiratory and Critical Care Medicine. 2000; 21(5):385-392. 139237
     View PubMed
116. Levitan N, Dowlati A, Shina D, Craffey M, Mackay W, DeVore R, Jett J, Remick S, Chang A, Johnson D. Multi-institutional phase I/II trial of paclitaxel cisplatin and etoposide with concurrent radiation for limited stage small cell lung carcinoma. Jour Clin Oncol , 2000; 18:1102-9. 146649
     
117. Kirschling RJ, Grill JP, Marks RS, Kugler JW, Gerstner JB, Kuross SA, Michalak JC, Windschitl HE, Krewer KD, Jett JR. Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group. Am J Clin Oncol. 1999 Oct; 22(5):517-22. 1009234
     View PubMed
118. Bonner JA, Sloan JA, Shanahan TG, Brooks BJ, Marks RS, Krook JE, Gerstner JB, Maksymiuk A, Levitt R, Mailliard JA, Tazelaar HD, Hillman S, Jett JR. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol. 1999 Sep; 17(9):2681-91. 1009191
     View PubMed
119. Jett JR. Is there a role for adjuvant therapy for resected non-small cell lung cancer? Thorax. 1999 Aug; 54 Suppl 2:S37-41. 1008872
     View PubMed
120. Marschke RF Jr, Grill JP, Sloan JA, Wender DB, Levitt R, Mailliard JA, Gerstner JB, Ghosh C, Morton RF, Jett JR. Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer. Am J Clin Oncol. 1999 Feb; 22(1):15-7. 109417
     View PubMed
121. Egan AJ, Boardman LA, Tazelaar HD, Swensen SJ, Jett JR, Yousem SA, Myers JL. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol. 1999 Jan; 23(1):17-26. 109082
     View PubMed
122. Maksymiuk AW, Marschke RF Jr, Tazelaar HD, Grill J, Nair S, Marks RS, Brooks BJ, Mailliard JA, Burton GM, Jett JR. Phase II trial of topotecan for the treatment of mesothelioma. Am J Clin Oncol. 1998 Dec; 21(6):610-3. 108862
     View PubMed
123. Przygodzki RM, Bennett WP, Guinee DG Jr, Khan MA, Freedman A, Shields PG, Travis WD, Jett JR, Tazelaar H, Pairolero P, Trastek V, Liotta LA, Harris CC, Caporaso NE. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. Pharmacogenetics. 1998 Dec; 8(6):503-11. 109101
     View PubMed
124. Bennett WP, el-Deiry WS, Rush WL, Guinee DG Jr, Freedman AN, Caporaso NE, Welsh JA, Jones RT, Borkowski A, Travis WD, Fleming MV, Trastek V, Pairolero PC, Tazelaar HD, Midthun D, Jett JR, Liotta LA, Harris CC. p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer. Clin Cancer Res. 1998 Jun; 4(6):1499-506. 2148798
     View PubMed
125. Ghaemmaghami M, Jett JR. New agents in the treatment of small cell lung cancer. Chest. 1998 Jan; 113(1 Suppl):86S-91S. 102805
     View PubMed
126. Fleming MV, Guinee DG Jr, Chu WS, Freedman AN, Caporaso NE, Bennett WP, Colby TV, Tazelaar H, Abbondanzo SL, Jett J, Pairolero P, Trastek V, Liotta LA, Harris CC, Travis WD. Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients. Hum Pathol. 1998 Jan; 29(1):60-4. 1021245
     View PubMed
127. Greenberger JS, Bahri S, Jett JR, Belani C, Kalend A, Epperly M. Considerations in optimizing radiation therapy for non-small cell lung cancer Chest. 1998; 113:46S-52S. 146644
     View PubMed
128. Midthun DE, Jett JR. Early detection of lung cancer: today's approach. J Respir Dis. 1998; 19(1):59-70. 104426
     
129. Arcasoy SM, Jett JR. Superior pulmonary sulcus tumors and panoasts-syndrome. N Engl J Med. 1997 Nov 6; 337(19):1370-1376. 100741
     View PubMed
130. Midthun DE, Jett JR. Chemotherapy for advanced lung cancer. When to expect a response. Postgrad Med. 1997 Mar; 101(3):187-8, 191-2, 194 passim. 101926
     View PubMed
131. Strollo DC, Rosado de Christenson ML, Jett JR. Primary mediastinal tumors. Part I. Tumors of the anterior mediastinum Chest. 1997; 112:511-22. 146633
     View PubMed
132. Jett JR, Feins R, Kvale P, McCloud T, Miller YW, Perry M, Sause W, Silvestri G, Stover D, Spiro S, Travis W. Pre-treatment evaluation of non-small cell lung cancer: Joint statement of the American Thoracic Society and European Respiratory Society Am J Resp Crit Care Med. 1997; 156:320-32. 146635
     View PubMed
133. Arcasoy SM, Bajwa MK, Jett JR. Non-hodgkin's lymphoma presenting as pancoast's syndrome Resp Med. 1997; 91:571-3. 146637
     
134. Ginsberg R, Cox J, Green M, Bulzebruck H, Grunenwald D, Harper P, Jett J, LeChevalier T, Mornex F, Scott C, Tsuchiya R. Consensus report: staging classification committee Lung Cancer. 1997; 17:S11-13. 146638
     View PubMed
135. Strollo DC, Rosado-di-Christenson ML, Jett JR. Primary mediastinal tumors. Part II. Tumors of the middle and posterior mediastinum Chest. 1997; 112:1334-57. 146640
     
136. Luketich JD, Jett JR. The current management of thymic tumors. Seminars in Respiratory and Critical Care Medicine. 1997; 18(4):375-381. 100006
     
137. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, Wender DB, Burch PA. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer. J Clin Oncol (Classic Papers and Current Comments) 1997; 2(1):253-7. 1296412
     
138. Harty LC, Guinee DG Jr, Travis WD, Bennett WP, Jett J, Colby TV, Tazelaar H, Trastek V, Pairolero P, Liotta LA, Harris CC, Caporaso NE. p53 mutations and occupational exposures in a surgical series of lung cancers. Cancer Epidemiol Biomarkers Prev. 1996 Dec; 5(12):997-1003. 98311
     View PubMed
139. Trivers GE, De Benedetti VM, Cawley HL, Caron G, Harrington AM, Bennett WP, Jett JR, Colby TV, Tazelaar H, Pairolero P, Miller RD, Harris CC. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res. 1996 Oct; 2(10):1767-75. 1025386
     View PubMed
140. Shaw EG, Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JR, Foote RL, Su JQ, Schaid DJ, Lee RE. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung. Am J Clin Oncol. 1996 Apr; 19(2):154-8. 95986
     View PubMed
141. Frytak S, Shaw EG, Jett JR, Richardson RL, Foote RL, Creagan ET, Eagan RT, Su JQ. Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer. Am J Clin Oncol. 1996 Apr; 19(2):193-8. 95987
     View PubMed
142. Castro M, Veeder MH, Mailliard JA, Tazelaar HD, Jett JR. A prospective study of pulmonary function in patients receiving mitomycin. Chest. 1996 Apr; 109(4):939-44. 96038
     View PubMed
143. Rowland KM, Loprinzi CL, Shaw EG, Maksymiuk AW, Kuross SA, Jung SH, Kugler JW, Tschetter LK, Ghosh C, Schaefer PL, Owen D, Washburn JH, Webb TA, Mailliard JA, Jett JR. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate placebo in extensive-stage small-cell lung cancer - a North Central Cancer Treatment Group study. J Clin Oncol. 1996 Jan; 14(1):135-141. 95318
     View PubMed
144. Ghaemmaghami M, Jett JR. Small cell lung cancer: current approaches J Resp Diseases Vol 1996 Dec; 17(2):1054-68. 146180
     
145. Jett JR. Primary lung cancer. Conn's Current Therapy. 1996; 182-188. 94801
     
146. Greenberger JS, Kalend A, Sciurba F, Jett JR, Landreneau RJ, Belani CP. Development of multifield three-dimensional conformal radiotherapy of lung cancer using a total lung dose/volume histogram. Radiat Oncol Investig. 1996; 3:243-255. 94802
     View PubMed
147. Jett JR, Kirschling RJ, Jung SH, Marks RS. A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: a study of the North Central Cancer Treatment Group. Semin Oncol. 1995 Jun; 22(3 Suppl 6):75-7. 92982
     View PubMed
148. Guinee DG Jr, Travis WD, Trivers GE, De Benedetti VM, Cawley H, Welsh JA, Bennett WP, Jett J, Colby TV, Tazelaar H, Abbondanzo SL, Pairolero P, Trastek V, Caporaso NE, Liotta LA, Harris CC. Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis. 1995 May; 16(5):993-1002. 1314105
     View PubMed
149. Midthun DE, Swensen SJ, Jett JR. Postepowanie w przypadku stwierdzenia pojedynczego cienia okraglego w plucu: Approach to the solitary pulmonary nodule Polish Journal of Medicine 1995 Jun; 2:45-53. 141833
     
150. Jett J, Kirschling R, Jung S, Marks R A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: A study of the North Central Cancer Treatment Group. (Presented at Taxol Investigators Workshop) Seminars in Oncology. 1995; 22:75-77. 2003215
     View PubMed
151. Jett JR, Su JQ, Krook JE, Goldberg RM, Kugler JW. Measurable or assessable disease in lung cancer trials: does it matter? J Clin Oncol. 1994 Dec; 12(12):2677-81. 89471
     View PubMed
152. Shaw EG, Su JQ, Eagan RT, Jett JR, Maksymiuk AW, Deigert FA. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. J Clin Oncol. 1994 Nov; 12(11):2327-32. 89559
     View PubMed
153. Jett JR, Maksymiuk AW, Su JQ, Mailliard JA, Krook JE, Tschetter LK, Kardinal CG, Twito DI, Levitt R, Gerstner JB. Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer. J Clin Oncol. 1994 Nov; 12(11):2321-6. 86573
     View PubMed
154. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, et al. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol. 1994 Jun; 12(6):1126-9. 2288920
     View PubMed
155. Liengswangwong V, Bonner JA, Shaw EG, Foote RL, Frytak S, Eagan RT, Jett JR, Richardson RL, Creagan ET, Su JQ. Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol. 1994 Mar; 12(3):496-502. 88282
     View PubMed
156. Bunn P, Arriagada R, Choi N, Feld R, Gregor A, Jett J, Johnson B, Komaki R, Kristjansen P, Murray N. Combined modality therapy in small cell lung cancer. Lung Cancer. 1994 Mar; 10(Suppl 1):S25-8. 86576
     View PubMed
157. Wiesenfeld M, Jett JR, Su JQ, Braich TA, Kardinal CG, Mailliard JA, Veeder MH, Morton RF, Michalak JC. Phase II trial of edatrexate in small cell lung cancer. Cancer. 1994 Feb 15; 73(4):1189-93. 87410
     View PubMed
158. Maksymiuk AW, Jett JR, Earle JD, Su JQ, Diegert FA, Mailliard JA, Kardinal CG, Krook JE, Veeder MH, Wiesenfeld M. Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial. J Clin Oncol. 1994 Jan; 12(1):70-6. 86577
     View PubMed
159. Wiesenfeld M, Jett J, Su J, Braich T, Kardinal C, Mailliard J, Veeder M, Morton R, Michalak J Phase II trial of edatrexate in small cell lung cancer Cancer. 1994; 73:1189-1193. 2003098
     View PubMed
160. Pujol J, Gibney DJ, Su JQ, Maksymiuk AW, Jett JR. Immune response induced in small-celled lung cancer by maintenance therapy with interferon gamma. J Natl Cancer Inst. 1993 Nov 17; 85:1844-1850. 84585
     View PubMed
161. Jett JR. Current treatment of unresectable lung cancer. Mayo Clin Proc. 1993 Jun; 68(6):603-11. 83899
     View PubMed
162. Gesme DH, Jett JR, Schreffler DD, Su JQ, Mailliard JA, Foley JF, Krook JE, Maksymiuk AW, Hatfield AK, Ebbert LP. A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment Group. Cancer. 1993 May 1; 71(9):2723-6. 82549
     View PubMed
163. Midthun DE, Swensen SJ, Jett JR. Approach to the solitary pulmonary nodule. Mayo Clin Proc. 1993 Apr; 68(4):378-85. 83235
     View PubMed
164. Shaw EG, McGinnis WL, Jett JR, Su JQ, Frank AR, Mailliard JA, Engel RE, Wiesenfeld M, Rowland KM Jr. Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung. J Natl Cancer Inst. 1993 Feb 17; 85(4):321-3. 82550
     View PubMed
165. Jett JR, Tazelaar HD. Lung cancer in the elderly. Lung Biol Health Dis. 1993; 63:61-80. 82747
     
166. Gesme D, Jett J, Schreffler D, Su J, Mailliard J, Foley J, Krook J, Maksymiuk A, Hatfield A, Ebbert L, Pfeifle D, Morton R, Tschetter L, Schaefer P A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer: A trial of the North Central Cancer Treatment Group Cancer. 1993; 71:2723-2726. 2003078
     View PubMed
167. Veeder MH, Jett JR, Su JQ, Mailliard JA, Foley JF, Dalton RJ, Etzell PS, Marschke RF, Kardinal CG, Maksymiuk AW, Ebbert LP, Tazelaar HD, Witrak GF. A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma. Cancer. 1992 Nov 1; 70(9):2281-7. 82454
     View PubMed
168. Reinoso MA, Jett JR, Beck KC. Body plethysmography in the evaluation of intrathoracic airway abnormalities. Chest. 1992 Jun; 101(6):1674-6. 80132
     View PubMed
169. Midthun DE, Swensen SJ, Jett JR. Clinical strategies for solitary pulmonary nodule. Annu Rev Med. 1992; 43:195-208. 82119
     View PubMed
170. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE, Elliott TE, Mailliard JA, Nelimark RA, Maksymiuk AW, et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med. 1991 Nov 1; 115(9):681-6. 75544
     View PubMed
171. Jett JR, Tazelaar HD, Keim LW, Ingrassia TS 3rd. Plastic bronchitis: an old disease revisited. Mayo Clin Proc. 1991 Mar; 66(3):305-11. 76098
     View PubMed
172. Holmes EC, Bleehen NM, LeChavalier T, Ettinger D, Jett JR, Johnson D, Komaki R, Saijo N, Sause W, Torovo M, VanHoutte P, Wulfrank D. Postoperative adjuvant treatments for non-small cell lung cancer: consumer report. Lung Cancer. 1991; 7:11-14. 75579
     
173. Morton R, Jett J, McGinnis W, Earle J, Therneau T, Krook J, Elliott T, Mailliard J, Nelimark R, Maksymiuk A, Drummond R, Laurie J, Kugler J, Anderson R Randomized phase III trial of thoracic radiation therapy alone versus combined chemoradiotherapy for locally unresectable non-small cell lung cancer Ann Intern Med. 1991; 115:681-686. 2003068
     View PubMed
174. Goldberg RM, Jett JR, Therneau TM, Johnson PS, Tschetter LK, Krook JE, Veeder MH, Owen D, Etzell PS, Andres DF. Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group. J Natl Cancer Inst. 1990 Dec 19; 82(24):1899-903. 71804
     View PubMed
175. Swensen SJ, Jett JR, Payne WS, Viggiano RW, Pairolero PC, Trastek VF. An integrated approach to evaluation of the solitary pulmonary nodule. Mayo Clin Proc. 1990 Feb; 65(2):173-86. 72121
     View PubMed
176. Jett JR, Everson L, Therneau TM, Krook JE, Dalton RJ, Marschke RF Jr, Veeder MH, Brunk SF, Mailliard JA, Twito DI, et al. Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group. J Clin Oncol. 1990 Jan; 8(1):33-8. 2106849
     View PubMed
177. Goldberg R, Jett J, Therneau T, Johnson P, Tschetter L, Krook J, Veeder M, Owen D, Etzell P, Andres D Bolus versus infusional etoposide and cisplatinum in treatment of non-small cell lung cancer: A study of the North Central Cancer Treatment Group J Natl Cancer Inst. 1990; 82:1899-1903. 2003054
     View PubMed
178. Robinow JS, Shaw EG, Eagan RT, Lee RE, Creagan ET, Frytak S, Richardson RL, Jett JR, Burton JK, Ilstrup DM. Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1989 Dec; 17(6):1203-10. 70377
     View PubMed
179. Jett JR. Is there a role for interferon in the treatment of small cell lung cancer? Lung Cancer. 1989 Dec; 5(4-6):281-6. 68330
     
180. Sanderson DR, Jett JR. Lung cancer: the American view. Eur Respir J. 1989 Nov; 2(10):1002-7. 68305
     View PubMed
181. Everson LK, Jett JR, O'Fallon JR, Krook JE, Dalton RJ, Mailliard JA, Tschetter LK, Cullinan SA, Gerstner JB, Morton RF. Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer. Am J Clin Oncol. 1989 Aug; 12(4):339-44. 1313455
     View PubMed
182. Krook JE, Jett JR, Little C. A phase I-II study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancer. Am J Clin Oncol. 1989 Apr; 12(2):114-7. 68306
     View PubMed
183. Frytak S, Shaw JN, O'Neill BP, Lee RE, Eagan RT, Shaw EG, Richardson RL, Coles DT, Jett JR. Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol. 1989 Feb; 12(1):27-33. 68551
     View PubMed
184. Everson L, Jett J, O'Fallon J, Krook J, Dalton R, Mailliard J, Tschetter L, Cullinan S, Gerstner J, Morton R, Laurie J Alternating chemotherapy with or without VP16 in extensive stage small cell lung cancer Am J Clin Oncol. 1989; 12(4):339-344. 2003032
     View PubMed
185. Krook J, Jett J, Little C A phase I-II study of sequential infusion VP16 and cisplatin therapy in advanced lung cancer Am J Clin Oncol. 1989; 12(2):114-117. 2003037
     View PubMed
186. Mohr DN, Jett JR. Preoperative evaluation of pulmonary risk factors. J Gen Intern Med. 1988 May-Jun; 3(3):277-87. 65348
     View PubMed
187. Eagan RT, Frytak S, Richardson RL, Creagan ET, Therneau TM, Coles DT, Jett JR. A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer. J Clin Oncol. 1988 Jan; 6(1):5-8. 64659
     View PubMed
188. Frytak S, Shaw JN, Lee RE, Eagan RT, Shaw EG, Richardson RL, Creagan ET, Coles DT, Jett JR. Treatment toxicities in long-term survivors of limited small cell lung cancer. Cancer Invest. 1988; 6(6):669-76. 67345
     View PubMed
189. Hong WS, Jett JR, Sasaki Y, Takahashi H, Nakano H, Nakagawa K, Hoshi A, Saijo N. Colony inhibitory effect of recombinant human tumor necrosis factor (rH-TNF) and/or recombinant human interferon (rH-IFN)-alpha, -beta and -gamma on human lung cancer cell lines. Jpn J Clin Oncol. 1987 Mar; 17(1):49-55. 60785
     View PubMed
190. Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JR, Coles DT, Lee RE. Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. Am J Clin Oncol. 1987 Feb; 10:33-35. 61254
     View PubMed
191. Ishihara J, Saijo N, Sasaki Y, Nakano H, Ozaki A, Takahashi H, Masanori S, Nakagawa K, Iigo M, Kanzawa F, Hoshi A, Hong WS, Jett JR, Takahashi T. The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines. Cancer Immunol Immunother. 1987; 24:185-189. 60796
     View PubMed
192. Jett JR, Saijo N, Hong WS, Sasaki Y, Takahashi H, Nakano H, Nakagawa K, Sakurai M, Suemasu K, Tesada M. The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell lines. Invest New Drugs. 1987; 5(2):155-9. 60783
     View PubMed
193. Takahashi H, Sasaki Y, Saijo N, Sakurai M, Nakano H, Nakagawa K, Hoshi A, Jett JR, Hong WS. In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin. Cancer Chemotherapy & Pharmacology. 1987; 19(3):197-200. 60784
     View PubMed
194. Adams VI, Unni KK, Muhm JR, Jett JR, Ilstrup DM, Bernatz PE. Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases. Cancer. 1986 Oct 1; 58(7):1540-51. 59135
     View PubMed
195. Suga J, Nagahiro S, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Sakurai M, Ono R, Takahashi H, Nakano H, Nakagawa K, Hoshi A, Jett JR. Long-term survival in patients with small cell lung cancer. Jpn J Clin Oncol. 1986 Sep; 16(3):309-315. 57413
     View PubMed
196. Sakurai M, Iigo M, Ozaki A, Jett JR, Sasaki Y, Hoshi A, Saijo N. Inhibitory effect of murine recombinant interferon (beta) on the pulmonary metastasis of B-16 melanoma. Jpn J Cancer Res. 1986 Aug; 77(8):774-81. 57402
     View PubMed
197. Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tominaga K, Sakurai M, Suga J, Miyaoka H, Sano T, Keicho N, Takahashi H, Ishihara J, Tamura T, Hoshi A, Jett JR. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin. Jpn J Cancer Res. 1986 Aug; 77(8):782-789. 57411
     View PubMed
198. Sano T, Saijo N, Sasaki Y, Shinkai T, Eguchi K, Tamura T, Sakurai M, Takahashi H, Nakano H, Tajiri H, Morinaga S, Itabashi M, Jett JR. A case report of synchronous small cell lung cancer and gastric cancer successfully treated with carboplatin. Jpn J Cancer Res. 1986 Aug; 77(8):790-798. 57412
     View PubMed
199. Eagan RT, Frytak S, Creagan ET, Richardson RL, Coles DT, Jett JR. Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP. Am J Clin Oncol. 1986 Jun; 9(3):249-54. 58745
     View PubMed
200. Sakurai M, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Sano T, Suemasu K, Jett JR. The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial. Jpn J Clin Oncol. 1986 Jun; 16(2):153-6. 57403
     View PubMed
201. Futami H, Sasaki Y, Sakurai M, Nomori H, Takahasi H, Ishihara J, Hoshi A, Koyama K, Hamburger AW, Jett JR. Differences of host immune response and of sensitivity to chemotherapeutic agents between two clones of rat fibrosarcoma with different metastatic potential. Jpn J Cancer Res. 1986 May; 77(5):480-486. 57410
     View PubMed
202. Mansel JK, Zinsmeister AR, Pairolero PC, Jett JR. Pulmonary resection of metastatic colorectal adenocarcinoma. A ten year experience. Chest. 1986 Jan; 89(1):109-12. 57404
     View PubMed
203. Krook JE, Jett JR, Fleming TR, Dalton RJ, Marschke RF, Cullinan SA, Windschitl HE, Everson LK, Brunk FS, Laurie JA, et al. A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer. J Clin Oncol. 1985 Jun; 3(6):842-8. 2148774
     View PubMed
204. Adams VI, Jett JR. Diffuse malignant mesothelioma: desmoplastic variant. Tumor Diagnosis and Treatment. 1984; 11(6):1-4. 53981
     
205. Berquist TH, Brown LR, May GR, Jett JR, Bernatz PE. Magnetic resonance imaging of the chest: a diagnostic comparison with computed tomography and hilar tomography. Magn Reson Imaging. 1984; 2(4):315-27. 52874
     View PubMed
206. Jett JR, Kuritsky JN, Katzmann JA, Homburger HA. Acquired immunodeficiency syndrome associated with blood-product transfusions. Ann Intern Med. 1983 Nov; 99(5):621-4. 49536
     View PubMed
207. Jett JR, Hollinger CG, Zinsmeister AR, Pairolero PC. Pulmonary resection of metastatic renal cell carcinoma. Chest. 1983 Oct; 84(4):442-5. 49330
     View PubMed
208. Ruiz-Arguelles A, Jett JR, Ritts RE Jr. Impaired generation of helper T cells in a patient with chronic mucocutaneous candidiases and malignant thymoma. J Clin Lab Immunol. 1983 Mar; 10:165-169. 48230
     View PubMed
209. Jett JR, Cortese DA, Fontana RS. Lung cancer: current concepts and prospects. CA Cancer J Clin. 1983 Mar-Apr; 33(2):74-86. 48383
     View PubMed
210. Jett JR, Eagan RT. Chemotherapy for malignant mesothelioma; CAMEO. Am J Clin Oncol. 1982 Aug; 5(4):429-31. 47708
     View PubMed
211. Jett JR, Hoffman TM, Connor RJ, Herberman RB. Effect of various immunoregulatory substances on the growth inhibitory activity (GIA) of human monocytes against lymphoblastoid cell lines. Immunopharmacology. 1982 Apr; 4(2):105-13. 47709
     View PubMed
212. Ruiz-Arguelles A, Jett JR, Ritts RE Jr. Stage-associated incidence of serum circulating immune complexes in patients with untreated bronchogenic carcinoma. Cancer Immunol Immunother. 1982; 12:197-201. 47273
     
213. Jett JR, Cortese DA, Dines DE. The value of bronchoscopy in the diagnosis of mycobacterial disease. A five-year experience. Chest. 1981 Nov; 80(5):575-8. 43658
     View PubMed
214. Jett JR, Mantovani A, Herberman RB. Augmentation of human monocyte-mediated cytolysis by interferon. Cell Immunol. 1980 Sep 1; 54(2):425-34. 41279
     View PubMed
215. Roder JC, Haliotis T, Klein M, Korec S, Jett JR, Ortaldo J, Heberman RB, Katz P, Fauci AS. A new immunodeficiency disorder in humans involving NK cells. Nature. 1980 Apr 10; 284(5756):553-5. 1312498
     View PubMed
216. Kellermann G, Jett JR, Luyten-Kellermann M, Moses HL, Fontana RS. Variation of microsomal mixed function oxidase(s) and human lung cancer. Cancer. 1980 Mar 15; 45(6):1438-42. 40045
     View PubMed
217. Klein M, Roder J, Haliotis T, Korec S, Jett JR, Herberman RB, et al. The Chediak-Higashi gene in humans. II. The selectivity of the defect in NK and ADCC function. J Exp Med. 1980; 151:1049-1058. 1312465
     View PubMed
218. Herberman RB, Ortaldo JR, Djeu JY, Holden HT, Jett J, Lang NP, Rubinstein M, Pestka S. Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages. Ann N Y Acad Sci. 1980; 350:63-71. 1312502
     View PubMed
219. Jett JR, Branum EL, Fontana RS, Taylor WF, Moses HL. Macromolecular binding of 3H-benzo(a)pyrene metabolites and lymphocyte transformation in patients with lung cancer, and in smoking and nonsmoking control subjects. Am Rev Respir Dis. 1979 Aug; 120(2):369-75. 38069
     View PubMed
220. Jett JR, Moses HL, Branum EL, Taylor WF, Fontana RS. Benzo(a)pyrene metabolism and blast transformation in peripheral blood mononuclear cells from smoking and nonsmoking populations and lung cancer patients. Cancer. 1978 Jan; 41(1):192-200. 36868
     View PubMed
221. Jett JR, Stobo JD, Moses HL. Aryl hydrocarbon hydroxylase activity in subpopulations of peripheral blood mononuclear cells. Cancer Res. 1978; 38:1979-1982. 36312
     View PubMed
222. Kellermann G, Luyten-Kellermann M, Jett JR, Moses HL, Fontana RS. Aryl hydrocarbon hydroxylase in man and lung cancer. Hum Genet Suppl. 1978; (1):161-8. 1312402